In vitro, BPC-157 has shown promising activity in models examining muscle, tendon, and epithelial cell recovery, as well as studies involving oxidative stress and inflammatory pathways
This prolonged receptor engagement provides sustained appetite suppression throughout the dosing interval
PMID: 3628078
However, since the body contains more types of tissue than only the tendons, it is widely believed that this emerging peptide can benefit a broader range of organs, including the: Ligament Muscle Gastrointestinal tissues (stomach and intestines) Skin Cornea Pancreas Liver Heart Bone How Does BPC-157 Work
The simplest way to keep them straight is by counting receptors: semaglutide acts on one (GLP-1), tirzepatide on two (GLP-1 and GIP), and retatrutide on three (GLP-1, GIP, and glucagon)